Spain surpassed others in Europe by avoiding politicized debate about Covid shots. Citizens also largely heeded the health guidance from their leaders.
Tag: Drugs (Pharmaceuticals)
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.
Will the Covid Vaccines Stop Omicron? Scientists Are Racing to Find Out.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
Canada Approves Pfizer’s Covid Vaccine for Kids 5 to 11
The move adds more than 2.8 million young people to those eligible for a shot.
Biden Administration Plans to Expand Covid Vaccine Production
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
Biden Administration Plans to Expand Covid Vaccine Production
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million People
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the Delta variant.
Pressure Grows on G20 Nations to Get Covid Vaccines to the Poor
The world’s leaders are focusing on preventing future pandemics, but experts say rich nations are not doing enough to help the poor survive the current one.
Merck Will Share Formula for Its Covid Pill With Poor Countries
The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.